Peptidomics for Cancer Diagnosis: Present and Future
- 26 July 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 5 (9) , 2079-2082
- https://doi.org/10.1021/pr060225u
Abstract
Analysis of peptides in biological fluids by mass spectrometry holds promise of providing diagnostic and prognostic information for cancer and other diseases. Before this technology is used clinically, it is important to understand its advantages and limitations. These are summarized, along with proposals, on how to proceed in the future. Keywords: peptidomics • proteomics • cancer markers • mass spectrometry • diagnosisKeywords
This publication has 17 references indexed in Scilit:
- Analysis of Albumin-Associated Peptides and Proteins from Ovarian Cancer PatientsClinical Chemistry, 2005
- High-Resolution Serum Proteomic Profiling of Alzheimer Disease Samples Reveals Disease-Specific, Carrier-Protein–Bound Mass SignaturesClinical Chemistry, 2005
- Influences of Blood Sample Processing on Low–Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass SpectrometryClinical Chemistry, 2005
- Analytical and Preanalytical Biases in Serum Proteomic Pattern Analysis for Breast Cancer DiagnosisClinical Chemistry, 2005
- Direct Tandem Mass Spectrometry Reveals Limitations in Protein Profiling Experiments for Plasma Biomarker DiscoveryJournal of Proteome Research, 2005
- Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian CancerJNCI Journal of the National Cancer Institute, 2005
- Bias as a threat to the validity of cancer molecular-marker researchNature Reviews Cancer, 2005
- Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential ProblemsJNCI Journal of the National Cancer Institute, 2004
- Proteomic applications for the early detection of cancerNature Reviews Cancer, 2003
- Peptidomics technologies for human body fluidsPublished by Elsevier ,2001